STAR1,211.00

Strides Pharma Science Ltd.

· Pharma & Health
₹ CrorePeersSPARCSUPRIYASHILPAMEDTHYROCARERUBICONVIYASHYATHARTHPARKHOSPSMcap ₹11,162 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt2,414.51,795.61,668.71,668.7
Net Debt2,147.71,613.51,480.01,480.0
Total Debt/Equity1.170.690.530.53
Net Debt/Equity1.040.620.470.47
Total Debt/EBITDA3.252.241.801.80
Net Debt/EBITDA2.892.011.601.58
Interest Coverage (EBIT/Interest)1.662.454.054.05
Total Debt/Total Capital %53.8240.9834.6334.63
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.